Steve Kanzer is a business professional with over two decades of experience in the biotechnology and pharmaceutical industry, with much of this time being spent with Accredited Ventures, where he serves as chairman and CEO and leads investments in the life sciences. In addition, Steve Kanzer has been involved with a variety of nonprofits and other organizations, including the New York University (NYU) School of Law.
The NYU School of Law recently held its annual conference, which focused on exploring regulatory and policy tools surrounding the ongoing opioid epidemic, which kills approximately 900 people each week across the United States. During the conference, which was held on September 26, a panel explored the potential use of class-action lawsuits. One of the panelists, Chief Judge Diane Wood, noted during the presentation that the settlements of these types of suits are often suspect in terms of their actually helping the plaintiffs.
The conference, which was hosted by NYU Law’s Classical Liberal Institute, the NYU Journal of Law & Business, and the Center on Civil Justice, welcomed speakers from a range of areas, including health law, litigation, and drug policy to discuss how the epidemic could be tackled in Congress and the courts.
There were a variety of panels during the event, with the second focusing on potential drug policy reforms and the current regulations surrounding the issue. One of the more notable discussions concentrated on educating people about the problem and helping to treat those who are addicted in various ways.
The NYU School of Law recently held its annual conference, which focused on exploring regulatory and policy tools surrounding the ongoing opioid epidemic, which kills approximately 900 people each week across the United States. During the conference, which was held on September 26, a panel explored the potential use of class-action lawsuits. One of the panelists, Chief Judge Diane Wood, noted during the presentation that the settlements of these types of suits are often suspect in terms of their actually helping the plaintiffs.
The conference, which was hosted by NYU Law’s Classical Liberal Institute, the NYU Journal of Law & Business, and the Center on Civil Justice, welcomed speakers from a range of areas, including health law, litigation, and drug policy to discuss how the epidemic could be tackled in Congress and the courts.
There were a variety of panels during the event, with the second focusing on potential drug policy reforms and the current regulations surrounding the issue. One of the more notable discussions concentrated on educating people about the problem and helping to treat those who are addicted in various ways.